Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

HOW LOW CAN YOU GO? DIAGNOSIS OF ACUTE HIV INFECTION AT VERY LOW HIV RNA LEVELS

By Enthusiast Inc MDMarch 5, 2018

…ago, when testing methodologies were less specific than with current technology. The RV254/SEARCH010 cohort has recruited participants with AHI in Thailand since 2009. A total 230,036 screening tests were done…

TUBERCULOSIS PREVENTIVE TREATMENT IN NEW VS EXISTING ANTIRETROVIRAL THERAPY PATIENTS

By Jimmy He PharmD, DScApril 27, 2020

…active TB disease. Accordingly, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is committed to providing TPT to the eligible 14 million PLHIV currently supported by this program. In…

PHOSPHORYLATED HIV-1 AS POTENTIAL CYTOTOXIC T LYMPHOCYTE (CTL) TARGETS

By Enthusiast Inc MDMarch 6, 2018

…Selected identified phosphorylated HIV-1 peptides were synthesized and tested for HLA class I binding. PBMCs from HIV-1 infected patients were stimulated with phosphorylated and non-phosphorylated peptides, followed by flow-cytometric analysis…

Vaccination with Autologous Dendritic Cells Pulsed with Autologous HIV-Infected Apoptotic Cells

By Enthusiast Inc MDSeptember 29, 2014

Background: We evaluated the safety, tolerability, and immunogenicity of a therapeutic HIV vaccine composed of autologous dendritic cells (DC) pulsed with autologous, inactivated, HIV-1 infected apoptotic cells (DC-HIV vaccine). Methodology:…

TCR SEQUENCING OF EPITOPE-SPECIFIC T CELLS FROM SARS-CoV-2 CONVALESCENT INDIVIDUALS

By Jimmy He PharmD, DScApril 4, 2022

…and performed TCR sequencing on epitope-specific T cells. Epitope mapping was performed by IFN? ELISpot on PBMC from SARS-CoV-2 convalescent patients with mild/moderate disease (n = 19 for S; n=15…

IMMUNE MARKERS AND TO TIME TO REBOUND DURING HIV TREATMENT INTERRUPTION IN ACTG A5345

By Jimmy He PharmD, DScApril 22, 2021

…HIV peptide pool stimulation (p=0.05), and trends for lower % polyfunctional CD4+ T cell responses to pol (p=0.07), env (p=0.06) and total HIV peptide pool (p=0.052). Although no single immune…

THE SAO PAULO PATIENT: LOSING CELLULAR IMMUNITY AND REEMERGENCE OF DISTINCT HIV

By Jimmy He PharmD, DScApril 22, 2021

…subjected to a 5-drug antiretroviral regimen + nicotinamide, a drug aimed at disrupting HIV latency and boosting cell-mediated immunity (NCT02961829). He had been in antiretroviral analytical treatment interruption (ATI) for…

Divergent HIV-Specific CD4 T-cell Response Profiles in HIV Vaccine Trials

By Enthusiast Inc MDSeptember 29, 2014

…via different routes, ALVAC prime/ AIDSVAX boosts, ALVAC prime/ Env protein boosts, DNA prime/ Ad5 boost, subtype B gp120 alone, and MVA alone. Chronically infected HIV specimens were used as…

HLA-B35:05 Is a Protective Allele With a Unique Structure Amongst CRF01_AE-Infected Thais

By Enthusiast Inc MDSeptember 29, 2014

…with subtype CRF01_AE, remain sparse. Although HLA-B*57 is a protective allele amongst Africans and Caucasians, its prevalence amongst Asians is lower than other ethnic groups. Methodology: 1) 557 HIV-1 CRF01_AE-infected…

IMPACT OF COVID-19 PANDEMIC ON HIV CARE IN BRAZIL

By Jimmy He PharmD, DScApril 22, 2021

In March 2020, the Brazilian Ministry of Health (MoH) announced COVID-19 countrywide community transmission and issued guidelines on social distancing measures. Using real life data, we aimed to analyze the…

←1
23456789101112131415161718192021222324252627
…2829303132…
3334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top